🔎 Trials Near Me

Akèy › Osteyosakòm › Tennessee › Memphis

Etid klinik pou Osteyosakòm nan Memphis, TN

10 etid pou Osteyosakòm ap chèche patisipan nan sit nan ak bò kote Memphis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

Ap rekriteFaz 2
  • Saint Jude Children's Research Hospital, Memphis
Laj 12 a 39 · Tout sèks · Mizajou Sep 29, 2026 · NCT04616560

Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma

Ap rekriteFaz 2
  • St. Jude Children's Research Hospital, Memphis
Jiska laj 21 · Tout sèks · Mizajou Sep 1, 2026 · NCT07428993

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Ap rekriteFaz 3
  • Saint Jude Children's Research Hospital, Memphis
Jiska laj 50 · Tout sèks · Mizajou Aug 25, 2026 · NCT05235165

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Ap rekriteFaz 1/2
  • Saint Jude Children's Research Hospital, Memphis
12 Months – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT04851119

Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma

Ap rekrite
  • St. Jude Children's Research Hospital, Memphis
Tout laj · Tout sèks · Mizajou Aug 21, 2026 · NCT07514819

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Ap rekriteFaz 1/2
  • St. Jude Children's Research Hospital, Memphis
Jiska laj 30 · Tout sèks · Mizajou Aug 3, 2026 · NCT06239272

Deep Phenotyping Gait Deficits in Orthopedic Manifestations of Pediatric Cancer Patients

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • St. Jude Children's Research Hospital, Memphis
Laj 5 a 20 · Tout sèks · Mizajou Jun 18, 2026 · NCT07502885

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

Ap rekriteFaz 1
  • St. Jude Children's Research Hospital, Memphis
Jiska laj 21 · Tout sèks · Mizajou May 19, 2026 · NCT04897321

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

Ap rekriteFaz 1/2
  • St. Jude Children's Research Hospital, Memphis
12 Months – 30 Years · Tout sèks · Mizajou May 19, 2026 · NCT04901702

Molecular Analysis Of Solid Tumors

Ap rekriteEtid obsèvasyon
  • St. Jude Children's Research Hospital, Memphis
Jiska laj 25 · Tout sèks · Mizajou Nov 12, 2025 · NCT01050296

Etid Osteyosakòm nan lòt vil

Lòt etid nan Memphis

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.